93 results
Page 3 of 5
424B5
g6fqhqbsw
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
k8tg5hfrvjoe5jho
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
e3sp xq3lri
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
424B5
cj871h
8 Nov 19
Prospectus supplement for primary offering
4:34pm
424B5
d0zxg4ed7pniq jvcbdc
2 Aug 19
Prospectus supplement for primary offering
4:40pm
424B5
qh71mjvr2 bs81qul
1 Aug 19
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
thcx829k
2 May 19
Agile Therapeutics Reports First Quarter 2019 Financial Results
4:25pm
8-K
9onoq9cjw8 wbut
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-99.1
95yv22n9ips4evcdmtj
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm